Shape Therapeutics
Overview
The unlimited potential of AI & RNA We started ShapeTX with the vision of repairing the genetic causes of disease. We’re realizing that vision by combining AI and RNA technology to make programmable RNA medicine available for everyone. You. And a universe of possibilities.
Funding and backers
Backers
1
NEA
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About Sorriso Pharmaceuticals Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment…
At RedRidge, we are leaders in the identification and development of biparatopic antibodies, designed to deliver exceptional efficacy…
Therna is pioneering programmable RNA medicines by uniting artificial intelligence with deep RNA biology and hands-on experimental…
In a universe of possibilities, WE SEE THINGS DIFFERENTLY WE […].
There are over 60 million people with heart failure worldwide. It is the leading cause of hospitalization in people over 65.
Realizing the potential of tissue-targeted RNA therapies. miRecule™ is a biotechnology company developing RNA therapies for cancer and…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
NEAVia a fund
673 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely